Good Evening, So far 2012 has been strong around here as we look to continue our streak.
Many have already made money on this chart the last few weeks and we have had success everytime we alerted you on it in the past.
Now the dust has settled and the shares have pulled back to an attractive price, so it`s time to get back to work and take advantage of this opportunity... AGAIN! Even Barchart.com is giving the thumbs up with a "Buy" rating which can be viewed here: HOT NEW ALERT Please begin your research and due diligence this evening on Medisafe 1 Technologies (MFTH).
MFTH has the worlds FIRST U.S. patented technology to eliminate administration of incorrect medications that are injected by hypodermic needles! Simply put, Medisafe has an ingenious protector device that fits over the portion of a syringe.
This protector device has a locking mechanism which ensures that when injecting a patient, only the correct medicine is released from the hypodermic needle after positive technology-based pre-matching of the prescribed medicine is verified with the specific patient.
The technology uses a barcode technology on the locking element which allows a doctor or nurse to release the medicine upon confirming a positive match.
So, MFTHs patented technology ensures that medications cannot be released from hypodermic needles without positive pre-matching between the medicine and its intended patient.
Hospitals have 400,000 drug related injuries each year that result in 98,000 accidental deaths in the U.S. alone! MFTH will make these accidental drug related accidents impossible to ever occur again and could save hospitals BILLIONS in lawsuits and other legal related costs! The annual cost of drug-related morbidity and mortality exceeds $177.4 billion per year, with 70% of it occurring in hospitals for an annual potential market size of $121.5 billion! Recently MFTH announced that the company`s Board of Directors approved a stock repurchase program coupled with the relief to shareholder dilution back in November are positive signals for Medisafe.
Under the program, MFTH is authorized to repurchase up to 10 million of its outstanding shares of common stock during the next 12 months at a price up to $0.10 per share on the open market or by conducting privately negotiated transactions, company CEO Jacob Elhadad said, "Medisafe 1 Technologies continues to progress in our efforts to bring further added value to our shareholders, the repurchase of shares will enable us to acquire additional technologies that augment our existing commercial product line." The repurchase program would cost up to $1,000,000 and is subject to obtaining third party financing for the program where Medisafe is currently in talks with financial intuitions for the Repurchase Program. These shares may also be utilized by Medisafe to acquire additional assets, in particular the acquisition of a Child life-saving medical device company currently in negotiation. This clearly is part of the 2012 growth strategy as the company continues to make improvements to the balance sheet, strategic partnerships and acquisitions.
MFTH has a history of becoming very active after they release news and if history repeats itself (remember past performances are not indicative of future results), this Medical Breakthrough gem, MFTH, could offer a solid opportunity for the early investors.
Remember that no matter how good a potential investment looks from the outside, we always encourage you to do your own due diligence. The best way to begin your research is to review the company`s website, latest press releases and always check out their filings with the SEC.
Intelligent traders use Stop Loss Orders to protect their investments. We highly recommend you do the same and never allow greed to get the best of you.
Book your profits when you can! Happy Trading! ------------------------------------------------------------------------------- ------------------------------------------------------------- Remember, we always encourage you to do your own due diligence. The best way to begin your research is to review the company`s website, latest press releases and always dig into their filings with the SEC.
Intelligent traders use Stop Loss Orders to protect their investments. We highly recommend you do the same and never allow greed to disrupt your strategy. Book your profits when you can! Disclaimer The disclaimer is to be read and fully understood before using our site or subscribing to our newsletter.
Please read our entire Disclaimer/Disclosure at http://www.pennypayday.com/disclaimer.aspx.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR NEWSLETTER.
Neither www.pennypayday.com nor its officers, directors, partners, employees or anyone involved in the publication of this website or newsletters (us or we) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. Past performance of companies profiled on our website is not indicative of future results. Some companies profiled within this website and/or newsletters may lack a liquid trading market for their securities and investing in such securities is highly speculative and carries a high degree of risk. Never invest in any security featured on our website or newsletters unless you can afford to lose your entire investment.
All material posted on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. By reading this website, you are accepting sole responsibility for your own investment decisions and you acknowledge that the information contained herein is provided solely for general discussion and informational purposes and, therefore, should not be considered to be complete, precise, accurate, or current investment advice. The decision to buy or sell any security that may be featured on our websites or newsletters is done solely at the subscribers own risk.
IF YOU DO NOT AGREE WITH THE TERMS SET FORTH IN THIS DISCLAIMER, YOU SHOULD UN SUBSCRIBE TO OUR NEWSLETTER AND EXIT OUR WEBSITE IMMEDIATELY. YOUR USE OF OUR WEBSITE AND THE INFORMATION PROVIDED HEREIN SHALL INDICATE YOUR CONSENT AND AGREEMENT TO THIS DISCLAIMER.
PENNYPAYDAY.COM (PPD) is NOT a registered investment adviser or broker/dealer in any jurisdiction whatsoever. PENNYPAYDAY.COM does not make any recommendations that the purchase of the securities of companies profiled in their email newsletters, alerts, or any part of the PENNYPAYDAY.COM website is suitable or advisable for any person or that an investment in such securities will be profitable. The information on this website or within email newsletters to subscribers is not designed to be used as the basis for an investment decision. The decision to buy or sell any security that may be featured by PENNYPAYDAY.COM is done solely at the subscribers own risk. PENNYPAYDAY.COM profiles are intended to be stock ideas, NOT recommendations. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. The purpose of this advertisement, like any advertising, is to provide coverage and awareness for the company. Never invest into a stock we discuss unless you are prepared to lose your entire investment. The stocks in this alert are priced at their highs since our original profile. Past performance is not an indicator of future returns. PENNYPAYDAY.COM has previously been compensated via bank wire transfer $11,000 by third-party Royal Import Inc.for email coverage of Medisafe 1 Technoliges Corp. (OTCBB:MFTH) which has since expired. PENNYPAYDAY.COM has previously been compensated via bank wire transfer $5,000 by third-party RDI LLC for email coverage of Medisafe 1 Technoliges Corp. (OTCBB:MFTH) which has since expired. PENNYPAYDAY.COM has recently been compensated via bank wire transfer $40,000 by third-party GCL Global Commerce for email coverage of Medisafe 1 Technoliges Corp. (OTCBB:MFTH). PENNYPAYDAY.COM will not buy or sell the stocks mentioned in this alert which can not affect the price of the stock.
The information provided in this advertisement is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country.
Everything stated in PENNYPAYDAY.COM alerts are based on my opinion and are to be used for entertainment purposes only.
PennyPayday // PO Box 542772 Grand Prairie, TX 75054 // 972-591-1180 // www.PennyPayday.com References 1. http://barchart.com/quotes/stocks/MFTH 2. http://www.pennypayday.com/
This message was sent to from:
Cream Consulting Group, Inc. | PO Box 542772 | Grand Prairie, Texas 75054
See Penny Pay Day's website for full disclaimer. Penny Pay Day may have received compensation for stock picks.